Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

Novavax Inc. closed 73.09% below its 52-week high of $23.86, which the company achieved on June 6th.

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...